72 filings
Page 2 of 4
8-K
kp0v9het
19 Apr 23
Entry into a Material Definitive Agreement
4:07pm
424B5
3ddhxtjqis qtbm
19 Apr 23
Prospectus supplement for primary offering
4:05pm
424B5
6ldhtnb
18 Apr 23
Prospectus supplement for primary offering
9:21am
8-K
3rk5f
18 Apr 23
Results of Operations and Financial Condition
9:04am
8-K
xaj229
6 Mar 23
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
4:05pm
8-K
zxn15tf kevsslc3
10 Nov 22
Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights
9:00am
8-K/A
2spjyw6 tms7vznc1s
19 Sep 22
Departure of Directors or Certain Officers
4:30pm
EFFECT
hfpqaux6jvjlc8j
22 Aug 22
Notice of effectiveness
12:15am
CORRESP
prl4r
17 Aug 22
Correspondence with SEC
12:00am
UPLOAD
b9nkg
17 Aug 22
Letter from SEC
12:00am
S-3
eo5qj 1zpht0qp0xa7
10 Aug 22
Shelf registration
4:39pm
8-K
3xh8p
10 Aug 22
Immuneering Reports Second Quarter 2022 Financial Results and Recent Business Highlights
4:05pm
8-K
aj19gjp8zgt1 wdoxqul
25 Jul 22
Departure of Directors or Certain Officers
7:00am
8-K
9xw64o cmvibdwd74av
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
3sqvrh9ouxz
10 May 22
Immuneering Reports First Quarter 2022 Financial Results and Recent Business Highlights
6:32am
DEFA14A
xxbb2wx
2 May 22
Additional proxy soliciting materials
7:03am